Analyst Reco. Immunome, Inc.

Equities

IMNM

US45257U1088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
15.7 ^USD	-2.18%		+10.88%	+46.73%

May. 31	Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target	MT
May. 21	Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target	May. 31	MT
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing	May. 21	MT
JPMorgan Starts Immunome With Overweight Rating, $24 Price Target	Apr. 30	MT
Guggenheim Starts Immunome With Buy Rating, $35 Price Target	Apr. 15	MT
Wedbush Adjusts Immunome's Price Target to $33 From $27, Maintains Outperform Rating	Apr. 01	MT
Wedbush Raises Immunome's PT to $27 From $19 on Heels of Announced Plans to Acquire AL101, AL102 From Ayala Pharmaceuticals; Keeps Outperform Rating	Feb. 07	MT
Wedbush Raises Immunome's PT to $19 From $12 After Acquiring IM-1021 From Zentalis Pharmaceuticals, Maintains Outperform Rating	Jan. 23	MT
Immunome Shares Rise After Wedbush Starts Coverage With outperform Rating	Dec. 19	MT
Wedbush Starts Immunome With Outperform Rating, $12 Price Target; Has Positive View for Early-Stage Pipeline of Targeted Cancer Therapies	Dec. 19	MT
Chardan Cuts Price Target on Immunome to $8 From $9, Maintains Buy Rating	23-03-17	MT
Cantor Fitzgerald Initiates Immunome's Coverage With Overweight Rating, Sets Price Target at $8	22-09-27	MT
Chardan Adjusts Immunome's Price Target to $9 From $16, Citing IMM-BCP-01 Launch Expectations, Stock Dilution From Future Capital Raises; Buy Rating Kept	22-05-13	MT
Cantor Fitzgerald Starts Immunome at Overweight with $35 Price Target	21-10-29	MT
IMMUNOME : Chardan Adjusts Price Target on Immunome to $21 From $18 on Q2 Update, Maintains Buy Rating	21-08-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer